Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tepper

Showing results (311-320 of 432) with videos related to

Pageof 44
Sort By:
The Journal of Headache and Pain|November 21, 2023
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trialMessoud Ashina, Stewart J Tepper, Astrid Gendolla, et al.
Nutrients|September 24, 2020
Time Course of Salivary Protein Responses to Cranberry-Derived Polyphenol Exposure as a Function of PROP Taster StatusNeeta Y Yousaf, Melania Melis, Mariano Mastinu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 6, 2003
MMPI personality profiles in patients with primary chronic daily headache: a case-control studyM E Bigal, F D Sheftell, A M Rapoport, et al.
The Journal of Headache and Pain|April 20, 2021
Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database studyStewart J Tepper, Juanzhi Fang, Pamela Vo, et al.
Scientific Reports|March 25, 2022
Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)Deena E Kuruvilla, Joseph I Mann, Stewart J Tepper, et al.
Headache|June 11, 2014
Treatment persistence and switching in triptan users: a systematic literature reviewAndrew J Messali, Mo Yang, Patrick Gillard, et al.
Patient Preference and Adherence|October 2, 2018
Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studiesVirginia L Stauffer, Ryan Sides, Michel Lanteri-Minet, et al.
Neurology and Therapy|January 18, 2024
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER StudyPatricia Pozo-Rosich, Messoud Ashina, Stewart J Tepper, et al.
Cephalalgia : an International Journal of Headache|June 11, 2026
A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the USStewart J Tepper, Aaron Jenkins, Simon Dagenais, et al.
AIDS Care|June 19, 2004
Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP)S L Marhefka, J J Farley, J R Rodrigue, et al.
Pageof 44

Showing results (311-320 of 432) with videos related to

Sort By:
Pageof 44
The Journal of Headache and Pain|November 21, 2023
Long-term effectiveness of eptinezumab in patients with migraine and prior preventive treatment failures: extension of a randomized controlled trialMessoud Ashina, Stewart J Tepper, Astrid Gendolla, et al.
Nutrients|September 24, 2020
Time Course of Salivary Protein Responses to Cranberry-Derived Polyphenol Exposure as a Function of PROP Taster StatusNeeta Y Yousaf, Melania Melis, Mariano Mastinu, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 6, 2003
MMPI personality profiles in patients with primary chronic daily headache: a case-control studyM E Bigal, F D Sheftell, A M Rapoport, et al.
The Journal of Headache and Pain|April 20, 2021
Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database studyStewart J Tepper, Juanzhi Fang, Pamela Vo, et al.
Scientific Reports|March 25, 2022
Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM)Deena E Kuruvilla, Joseph I Mann, Stewart J Tepper, et al.
Headache|June 11, 2014
Treatment persistence and switching in triptan users: a systematic literature reviewAndrew J Messali, Mo Yang, Patrick Gillard, et al.
Patient Preference and Adherence|October 2, 2018
Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studiesVirginia L Stauffer, Ryan Sides, Michel Lanteri-Minet, et al.
Neurology and Therapy|January 18, 2024
Eptinezumab Demonstrated Efficacy Regardless of Prior Preventive Migraine Treatment Failure Type: Post Hoc Analyses of the DELIVER StudyPatricia Pozo-Rosich, Messoud Ashina, Stewart J Tepper, et al.
Cephalalgia : an International Journal of Headache|June 11, 2026
A retrospective cohort study comparing treatment persistence between rimegepant and lasmiditan for the acute treatment of migraine in the USStewart J Tepper, Aaron Jenkins, Simon Dagenais, et al.
AIDS Care|June 19, 2004
Clinical assessment of medication adherence among HIV-infected children: examination of the Treatment Interview Protocol (TIP)S L Marhefka, J J Farley, J R Rodrigue, et al.
Pageof 44